MedPath

Needle Guidance in Ultrasound Guided Nerve Blocks

Not Applicable
Completed
Conditions
Elective Knee Surgery
Interventions
Device: Infiniti Plus needle guidance system
Device: Conventional block needle
Registration Number
NCT02080481
Lead Sponsor
The Cleveland Clinic
Brief Summary

An FDA-approved product, InfinitiPlus (TM), is a needle guidance system that has been recently developed to guide clinicians in performing ultrasound guided nerve blocks. This system helps the clinician to align the needle with ultrasound beam while performing an ultrasound guided nerve block. InfinitiPlus (TM) has a unique open channel design allowing efficient needle movement while having improved needle shaft and tip visualization. This is a disposable system specifically designed for improving success rate of ultrasound guided block and patient safety.

This study will be done with patients having elective knee surgery and a femoral nerve block with a catheter. The nerve block procedure will be performed under ultrasound guidance to help improve safety and efficacy of the injection. InfinitiPlus (TM) has been recently developed to try to improve needle guidance in the ultrasound guided nerve block procedure. This study will determine whether femoral nerve block procedures performed under ultrasound guidance with InfinitiPlus (TM) take less time than procedures performed with ultrasound guidance and a conventional block needle. The study will also determine whether the InfinitiPlus (TM) needle reduces the number of times the clinician attempts the procedure, reduces the cost of the procedure, increases the procedure success rate, and improves ultrasound visibility of the needle.

Participants will be randomly assigned to either ultrasound guidance with the InfinitiPlus (TM) needle guidance system or ultrasound guidance with a conventional block needle. After surgery, pain will be rated every 30 minutes for the first 2 hours, then every 4 hours while awake for 24 hours. 24 hours after surgery, participants will be given a survey about pain treatment satisfaction and a questionnaire about recovery.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
135
Inclusion Criteria
  • Men or women 18-85 years old
  • Scheduled for elective knee surgery and expected to receive a femoral nerve block and catheter
  • Written informed consent
Exclusion Criteria
  • Contraindications to femoral block such as coagulopathy, infection at the needle insertion site and allergy to local anesthetics
  • Pregnancy
  • Preexisting neuropathy involving the surgical limb

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Infiniti Plus needle guidance systemInfiniti Plus needle guidance systemultrasound guidance with the InfinitiPlus (TM) needle guidance system
conventional block needleConventional block needleultrasound guidance with a conventional block needle
Primary Outcome Measures
NameTimeMethod
Time Spent in Performing Ultrasound Guided Femoral Nerve Blocks With InfinitiPlusTM Needle Guidance Systemtime elapsed from beginning the block procedure (after prepping and draping) until the catheter was successfully inserted or the end of the day of surgery.
Secondary Outcome Measures
NameTimeMethod
Block Failurestart of surgery until femoral nerve block completion

Number of patients who had block failure

> 1 Block Attemptfrom start of block procedure until block placement

Number of block attempts was collected for each patient as \> 1 block attempt versus 1 attempt. A block attempt was defined as pulling the block needle back to skin and redirecting it.

Percentage of Time With Perfect Needle VisibilityFrom start of block procedure until block placement

Percentage of time that perfect needle visibility was visualized on ultrasound.

Trial Locations

Locations (1)

Cleveland Clinic

🇺🇸

Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath